DEPTOR as a novel prognostic marker inhibits the proliferation via deactivating mTOR signaling pathway in gastric cancer cells

• Published in: Experimental cell research Vol. 427; no. 1; p. 113598
• Main Authors: Ma, Gang, Sun, Yi, Cai, Fenglin, Zhang, Mengmeng, Liang, Han, Deng, Jingyu, Zhang, Rupeng, Zhang, Li
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2023
• Subjects: Cabergoline; Cell Line, Tumor; DEPTOR; Gastric cancer; Humans; Intracellular Signaling Peptides and Proteins - genetics; Intracellular Signaling Peptides and Proteins - metabolism; mTOR; Prognosis; Proliferation; Signal Transduction; Stomach Neoplasms - genetics; TOR Serine-Threonine Kinases - genetics; TOR Serine-Threonine Kinases - metabolism; mTOR; DEPTOR; Proliferation; Cabergoline; Gastric cancer
• ISSN: 0014-4827; 1090-2422
• DOI: 10.1016/j.yexcr.2023.113598

Aberrantly activated mTOR signaling pathway is commonly found in malignancies including gastric cancer (GC). DEPTOR, as a naturally occurred inhibitor of mTOR, functions in the pro- or anti-tumor manner depending on distinct tumor contexts. However, the roles of DEPTOR in GC remain largely unknown. In this study, DEPTOR expression was identified to be significantly decreased in GC tissues compared with matched normal gastric tissues, and reduced DEPTOR level was indicative of poor prognosis in patients. Restored DEPTOR expression inhibited the propagation in AGS and NCI–N87 cells, whose DEPTOR levels are low, via deactivating mTOR signaling pathway. Likewise, cabergoline (CAB) attenuated the proliferation in AGS and NCI–N87 cells via partially rescuing DEPTOR protein level. Targeted metabolomics analysis showed that several key metabolites, such as l-serine, significantly changed in AGS cells with DEPTOR restoration. These results revealed the anti-proliferation function of DEPTOR in GC cells, suggesting that restored DEPTOR expression using CAB may be a potential therapeutic approach for patients with GC.